Natriumklorid-Glucos Viaflo Baxter (Sodium Chloride, Glucose)

Sodium chloride, the active ingredient in Natriumklorid-Glucos Viaflo Baxter, is a IV electrolyte solution presented as an injection solution for intravenous use. It is employed to restore extracellular fluid volume, correct electrolyte imbalances, and provide metabolic energy when combined with glucose in patients requiring fluid replacement or hypoglycemia management.

GNH USA supplies Natriumklorid-Glucos Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumklorid-Glucos Viaflo Baxter is used in clinical situations that require rapid fluid and electrolyte restoration. - Fluid replacement: rehydrates patients and expands intravascular volume during dehydration or blood loss. - Electrolyte imbalance correction: normalizes sodium and chloride concentrations in conditions such as hyponatremia. - Hypoglycemia (with dextrose): supplies glucose for metabolic energy when combined with dextrose in low‑blood‑sugar emergencies.

Adverse reactions may occur with any intravenous electrolyte solution. Monitoring during administration is recommended.

Common Side Effects: - Local irritation at the infusion site. - Mild hypernatremia if administered excessively. - Transient hyperglycemia when glucose is included. - Phlebitis or thrombophlebitis. - Allergic skin rash. - Nausea or vomiting.

Serious or Rare Side Effects: - Severe hypernatremia leading to neurological symptoms. - Anaphylactic reaction or severe hypersensitivity. - Pulmonary edema from rapid volume overload. - Metabolic acidosis if administered inappropriately. - Electrolyte disturbances such as hyperchloremic acidosis. - Cardiac arrhythmias due to electrolyte shifts.

Prior to administration, assess patient fluid status, electrolyte levels, and glucose tolerance. - Volume assessment: ensure appropriate fluid balance to avoid overload. - Electrolyte monitoring: check serum sodium and chloride before and during therapy. - Glucose monitoring: verify blood glucose levels when glucose is included. - Renal function: adjust volume in patients with impaired kidney function. - Infusion rate: administer at recommended rate to prevent rapid shifts. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Certain drugs may alter the efficacy or safety of the solution when given concurrently.

Major Interactions (Avoid): - Loop diuretics: may exacerbate electrolyte loss. - Hypertonic glucose solutions: increase risk of hyperglycemia. - Sodium‑containing medications: can cause cumulative sodium excess.

Moderate Interactions (Monitor Closely): - Insulin therapy: may require glucose dose adjustment. - ACE inhibitors or ARBs: monitor renal function and potassium levels. - Anticoagulants: observe for changes in bleeding risk due to volume shifts.